These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 20865640
61. Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells. Heinen S, Józsi M, Hartmann A, Noris M, Remuzzi G, Skerka C, Zipfel PF. J Am Soc Nephrol; 2007 Feb; 18(2):506-14. PubMed ID: 17229916 [Abstract] [Full Text] [Related]
62. [Clinical characteristies of atypical hemolytie uremic syndrome associated with H factor antibody in children]. Guan N, Liu X, Yao Y, Yang J, Wang F, Xiao H, Ding J, Zhao M, Yu F, Wang F. Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):223-6. PubMed ID: 24824395 [Abstract] [Full Text] [Related]
63. Association of a factor H mutation with hemolytic uremic syndrome following a diarrheal illness. Edey MM, Mead PA, Saunders RE, Strain L, Perkins SJ, Goodship TH, Kanagasundaram NS. Am J Kidney Dis; 2008 Mar; 51(3):487-90. PubMed ID: 18295065 [Abstract] [Full Text] [Related]
64. Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS). Roumenina LT, Roquigny R, Blanc C, Poulain N, Ngo S, Dragon-Durey MA, Frémeaux-Bacchi V. Methods Mol Biol; 2014 Mar; 1100():237-47. PubMed ID: 24218264 [Abstract] [Full Text] [Related]
65. Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T. Waters AM, Pappworth I, Marchbank K, Bockenhauer D, Tullus K, Pickering MC, Strain L, Sebire N, Shroff R, Marks SD, Goodship TH, Rees L. Am J Transplant; 2010 Jan; 10(1):168-72. PubMed ID: 19951285 [Abstract] [Full Text] [Related]
66. A case of atypical hemolytic uremic syndrome due to anti-factor H antibody in a patient presenting with a factor XII deficiency identified two novel mutations. Matsukuma E, Gotoh Y, Kuroyanagi Y, Yamada T, Iwasa M, Yamakawa S, Nagai T, Takagi N, Mae H, Iijima K, Bresin E. Clin Exp Nephrol; 2011 Apr; 15(2):269-74. PubMed ID: 21271273 [Abstract] [Full Text] [Related]
67. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome. Kavanagh D, Richards A, Fremeaux-Bacchi V, Noris M, Goodship T, Remuzzi G, Atkinson JP. Clin J Am Soc Nephrol; 2007 May; 2(3):591-6. PubMed ID: 17699467 [No Abstract] [Full Text] [Related]
68. Diagnosis and classification of hemolytic uremic syndrome: the Hungarian experience. Reusz GS, Szabó AJ, Réti M, Györke Z, Szilágyi Á, Farkas P, Prohászka Z. Transplant Proc; 2011 May; 43(4):1247-9. PubMed ID: 21620101 [Abstract] [Full Text] [Related]
69. [Hemolytic-uremic syndrome with renal thrombotic microangiopathy]. Kanfer A. Rev Prat; 1994 May 01; 44(9):1205-10. PubMed ID: 7939344 [Abstract] [Full Text] [Related]
70. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Abarrategui-Garrido C, Martínez-Barricarte R, López-Trascasa M, de Córdoba SR, Sánchez-Corral P. Blood; 2009 Nov 05; 114(19):4261-71. PubMed ID: 19745068 [Abstract] [Full Text] [Related]
71. Atypical hemolytic-uremic syndrome: the interplay between complements and the coagulation system. Nayer A, Asif A. Iran J Kidney Dis; 2013 Sep 05; 7(5):340-5. PubMed ID: 24072143 [Abstract] [Full Text] [Related]
72. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review. Bosch T, Wendler T. Ther Apher; 2001 Jun 05; 5(3):182-5. PubMed ID: 11467754 [Abstract] [Full Text] [Related]
73. Where next with atypical hemolytic uremic syndrome? Jokiranta TS, Zipfel PF, Fremeaux-Bacchi V, Taylor CM, Goodship TJ, Noris M. Mol Immunol; 2007 Sep 05; 44(16):3889-900. PubMed ID: 17768107 [Abstract] [Full Text] [Related]
74. Successful therapeutic plasma exchange in a 3.2-kg body weight neonate with atypical hemolytic uremic syndrome. Jung S, Kang ES, Ki CS, Kim DW, Paik KH, Chang YS. J Clin Apher; 2011 Sep 05; 26(3):162-5. PubMed ID: 21322001 [Abstract] [Full Text] [Related]
75. [Hemolytic and uremic syndrome in the child]. Niaudet P. Nephrol Ther; 2008 Feb 05; 4(1):34-40. PubMed ID: 17964233 [Abstract] [Full Text] [Related]
76. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Nilsson SC, Karpman D, Vaziri-Sani F, Kristoffersson AC, Salomon R, Provot F, Fremeaux-Bacchi V, Trouw LA, Blom AM. Mol Immunol; 2007 Mar 05; 44(8):1835-44. PubMed ID: 17084897 [Abstract] [Full Text] [Related]
77. Hemolytic uremic syndrome with simultaneous Shiga toxin producing Escherichia coli and complement abnormalities. McCoy N, Weaver DJ. BMC Pediatr; 2014 Nov 05; 14():278. PubMed ID: 25373393 [Abstract] [Full Text] [Related]
78. Hemolytic uremic syndrome in a developing country: Consensus guidelines. Bagga A, Khandelwal P, Mishra K, Thergaonkar R, Vasudevan A, Sharma J, Patnaik SK, Sinha A, Sethi S, Hari P, Dragon-Durey MA, Indian Society of Pediatric Nephrology. Pediatr Nephrol; 2019 Aug 05; 34(8):1465-1482. PubMed ID: 30989342 [Abstract] [Full Text] [Related]